Pan-Asia Index Flows & Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Equity Analyst with experience in fundamental and event-driven research in Frontier and Emerging markets. 

On Smartkarma, I mainly publish insights on index flow events in the Asia-Pacific region. This includes predicting regular and intra-review index changes and estimating upcoming passive flows. I also cover special situations such as mergers & acquisitions, equity offerings, buybacks, and other corporate restructuring events.

Pan-Asia Index Flows & Special Situations

Fubon Financial Holding Co (2881 TT): Rights Issue

Fubon Financial Rights - Common Share Rights Should Be Exercised, Pref Rights Are Worth Near Zero

EnTie (2849 TT) - IBF (2889 TT): US$1.2bn Cash & Scrip Deal Far From Done

China Life (2823 TT) Partial Offer : Arb Grids & Comps

Quiddity Advisors

Pan-Asia Catalysts/Events

Event-Driven

<p>Roughly 4 years ago, in Sep 2017, Taiwan-based financial services group <a href="https://www.smartkarma.com/entities/china-development-financial" target="_blank" data-smartkarma-citation="entities:13818:1" rel="noopener">China Development Financial (2883 TT)</a> ("CDFHC") became the top shareholder of <a href="https://www.smartkarma.com/entities/china-life-insurance-co-ltd" target="_blank" data-smartkarma-citation="entities:603:1" rel="noopener">China Life Insurance (2823 TT)</a> by launching a Tender Offer and acquiring a 25.33% stake for NT$30.8bn. At that time, China Life Insurance was the fifth largest insurance group in Taiwan.</p><p>Almost 3 years later, CDFHC made another Tender Offer to acquire an additional 21.1% stake in China Life Insurance for NT$23.6bn on 27th November 2020 increasing their direct shareholding to 47.3%. This Offer was completed in February 2021 and together with an 8.66% owned by a fully-owned subsidiary -  KGI securities - CDFHC collectively controlled around 56% in China Life Insurance. </p><p>Last week, on 12th August 2021, CDFHC announced a cash and scrip Deal to buy the remaining portion of China Life Insurance to take their ownership to 100% and delist the company from the Taiwan Stock Exchange.  </p><p>Under this Deal, China Life Insurance minority shareholders are expected to receive a combination of 0.80 CDFHC common shares, 0.73 CDFHC preferred shares, and NT$11.5 in cash for each share of China Life Insurance they own. The Deal is conditional on receiving shareholder approvals and regulatory approvals and is expected to complete by the end of this year. </p><div><p><em>More below the fold. </em></p></div><hr><div><div><div class="content-remarks"><p style="text-align: left;"><em>For more information about M&amp;A rules, regulations, and practices in Australia, please refer to <a href="https://www.smartkarma.com/insights/quiddity-taiwan-m-a-guide-2019" target="_blank" data-smartkarma-citation="insights:30640" rel="noopener">Quiddity Taiwan M&amp;A Guide 2019</a></em></p></div></div></div>

Roughly 4 years ago, in Sep 2017, Taiwan-based financial services group China Development Financial (2883 TT) ("CDFHC") became the top shareholder of China Life Insurance (2823 TT) by launching a Tender Offer and acquiring a 25.33% stake for NT$30.8bn. At that time, China Life Insurance was the fifth largest insurance group in Taiwan.Almost 3 years later, CDFHC made another Tender Offer to acquire an additional 21.1% stake in China Life Insurance for NT$23.6bn on 27th November 2020 increasing their direct shareholding to 47.3%. This Offer was completed in February 2021 and together with an 8.66% owned by a fully-owned subsidiary -  KGI securities - CDFHC collectively controlled around 56% in China Life Insurance. Last week, on 12th August 2021, CDFHC announced a cash and scrip Deal to buy the remaining portion of China Life Insurance to take their ownership to 100% and delist the company from the Taiwan Stock Exchange.  Under this Deal, China Life Insurance minority shareholders are expected to receive a combination of 0.80 CDFHC common shares, 0.73 CDFHC preferred shares, and NT$11.5 in cash for each share of China Life Insurance they own. The Deal is conditional on receiving shareholder approvals and regulatory approvals and is expected to complete by the end of this year. More below the fold. For more information about M&amp;A rules, regulations, and practices in Australia, please refer to Quiddity Taiwan M&amp;A Guide 2019

CDFHC - China Life Insurance: US$2bn+ Cash & Scrip Deal to Reach the Finish Line